Published on


Emergency and Acute Medicine: Ventricular Fibrillation




Ventricular fibrillation (VF) is a life-threatening cardiac arrhythmia characterized by completely disorganized electrical activity in the ventricles, resulting in ineffective myocardial contraction and absence of cardiac output. On cardiac monitoring, VF appears as chaotic, irregular oscillations without identifiable QRS complexes or T waves. Without immediate treatment, it rapidly leads to death.


The underlying mechanism of VF typically involves re-entrant electrical circuits within damaged myocardium. The most common cause is acute myocardial ischemia, particularly during ST-elevation myocardial infarction, where a significant proportion of cases occur within the first 24 hours. Other cardiac causes include cardiomyopathies, such as dilated or hypertrophic cardiomyopathy, which predispose patients to malignant arrhythmias. Nonischemic causes include drug toxicity (e.g., tricyclic antidepressants or digoxin), electrolyte abnormalities, acid–base disturbances, and inherited channelopathies such as long QT syndrome or Brugada syndrome. Additional triggers include hypoxia, hypothermia, electrocution, and blunt chest trauma.


Clinically, VF presents abruptly with loss of consciousness due to cessation of cerebral perfusion. Patients may exhibit brief seizure-like activity or gasping respirations before progressing to apnea. On examination, there is no palpable pulse or heart sounds, and the condition represents a form of cardiac arrest. If untreated, VF is fatal within minutes, making it one of the most critical emergencies in medicine.


Diagnosis is made immediately using a cardiac monitor or automated external defibrillator (AED), which identifies VF as a shockable rhythm. Differentiation from asystole is important, as fine VF may mimic a flatline; checking multiple leads can help detect subtle fibrillatory activity. Laboratory investigations are not useful during active resuscitation but become important after return of spontaneous circulation (ROSC) to identify reversible causes.


Management of VF is centered on rapid defibrillation and high-quality cardiopulmonary resuscitation (CPR). Early defibrillation is the single most important determinant of survival, with each minute of delay reducing survival by approximately 7–10%. Treatment follows advanced cardiac life support principles, beginning with immediate unsynchronized defibrillation using biphasic energy (typically 120–200 J), followed by uninterrupted CPR for 2 minutes. This cycle of shock and CPR continues until a perfusing rhythm is restored or resuscitation is terminated.


Pharmacologic therapy is used in refractory VF. Epinephrine is administered after the second shock and repeated every 3–5 minutes to improve coronary perfusion pressure. If VF persists after the third shock, antiarrhythmic drugs such as Amiodarone are recommended, with Lidocaine as an alternative. Magnesium sulfate may be given in cases of torsades de pointes. Establishing intravenous or intraosseous access and managing the airway are important but should never delay defibrillation or CPR.


After ROSC, management focuses on identifying and treating the underlying cause, most commonly acute coronary occlusion, which may require urgent reperfusion therapy such as percutaneous coronary intervention. Supportive care includes maintaining adequate oxygenation, blood pressure, and ventilation, as well as targeted temperature management to reduce neurologic injury. Monitoring includes ECG, cardiac biomarkers, and imaging such as echocardiography.


All patients who survive a VF arrest require admission to an intensive care unit for close monitoring and further management. Long-term considerations may include evaluation for implantable cardioverter-defibrillator placement, especially in patients at high risk of recurrence. Prevention strategies include correcting electrolyte abnormalities and maintaining adequate potassium levels, particularly in patients with myocardial infarction.


In summary, ventricular fibrillation is a rapidly fatal arrhythmia that demands immediate recognition and treatment. Prompt defibrillation, effective CPR, and systematic post-resuscitation care are essential to improving survival outcomes.

Picture
0 Comments